India's Piramal Pharma up on launching in-vitro biology capabilities
** Shares of Piramal Pharma PIRM.NS rise as much as 4% to
100.8 rupees
** Pharmaceutical co launches in-vitro biology capabilities
at its Ahmedabad drug discovery site
** Nearly 2.2 mln shares change hands by 09:40 a.m. IST,
0.5x its 30-day avg
** Stock currently up 2.9%, trimming YTD losses to nearly
10%
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio